<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CD120AEA-FB8C-4583-B0C3-A460490BE9F3"><gtr:id>CD120AEA-FB8C-4583-B0C3-A460490BE9F3</gtr:id><gtr:firstName>Dimitri</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Kullmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6D1B1118-CA7E-4E05-9D25-5F973190635B"><gtr:id>6D1B1118-CA7E-4E05-9D25-5F973190635B</gtr:id><gtr:firstName>Dmitri</gtr:firstName><gtr:surname>Rusakov</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C1298F3A-82A1-4629-B158-1A8051D4927D"><gtr:id>C1298F3A-82A1-4629-B158-1A8051D4927D</gtr:id><gtr:firstName>Arnaud</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Ruiz</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801316"><gtr:id>9991C4A2-F7C0-45DE-995D-C6E8BE58B883</gtr:id><gtr:title>Presynaptic ion channel dysfunction in the forebrain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801316</gtr:grantReference><gtr:abstractText>Epilepsy and migraine are common and frequently disabling diseases that often do not respond to available medication. They both show a strong genetic influence, and most of the genes that have been identified to cause epilepsy or migraine encode proteins that mediate the flux of charged ions across the membranes of neurons. How abnormalities of these proteins cause episodic disturbances of brain function is not known. Although some progress has been made in documenting whether individual mutations increase or decrease the flux of ions, and under which conditions, the consequences for neuronal firing and signalling among neurons remain incompletely understood. Our work addresses these questions by applying advanced optical and electrical measurements to individual neurons in the brain.</gtr:abstractText><gtr:technicalSummary>Idiopathic epilepsy and related paroxysmal disorders such as migraine represent an immense burden to the individual and to society. Ion channel dysfunction is thought to underlie much of the risk to the individual of developing these diseases. Monogenic channelopathies, manifesting as epilepsy, migraine or episodic ataxia, offer a unique window into the mechanisms by which altered ion channel function can give rise to paroxysmal CNS diseases. Although much is known about how disease-associated mutations affect the function of ion channels in heterologous expression, the consequences of these abnormalities for neuronal function in situ are poorly understood. The goal of the proposed work is to shed light on how mutations of two presynaptic ion channels (Kv1.1 and CaV2.1) affect action potential integration and neurotransmitter release in the hippocampus. We will apply advanced optical and electrophysiological methods, which we have recently optimised to examine mossy fibre signalling, in animal models of diseases caused by mutations of these channels. This work promises to shed light both on the normal roles of K+ and Ca2+ channels in the forebrain and how abnormalities in these channels can lead to seizures and other paroxysmal disturbances of brain function.</gtr:technicalSummary><gtr:fund><gtr:end>2012-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>910084</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy London UCL</gtr:department><gtr:description>School of Pharmacy</gtr:description><gtr:id>E58F1D72-FF78-4F3E-8E7E-D6F4290753E2</gtr:id><gtr:impact>Joint publication</gtr:impact><gtr:partnerContribution>Expertise in ion channel recordings from presynaptic boutons</gtr:partnerContribution><gtr:piContribution>Mouse mutants</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The invention provides methods and materials for treating a seizure disorder such as epilepsy in a patient which employ a vector encoding a modified receptor, the so-called &amp;quot;DREADD&amp;quot; receptor being characterised by (i) a decreased responsiveness to its endogenous activating ligand (ii) a retained or enhanced responsiveness to an exogenous agonist. The modified receptor is expressed in neurons of a seizure focus in brain of the patient, and an exogenous agonist is administered which activates the modified receptor to reversibly alters the excitability of the neurons in the seizure focus leading to synaptic silencing or other inhibition.</gtr:description><gtr:id>09D29562-AEB8-41EB-B891-B27857281A9B</gtr:id><gtr:impact>We are seeking investment to take this to clinical trials</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>WO2015136247</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>COMBINED USE OF A VECTOR ENCODING A MODIFIED RECEPTOR AND ITS EXOGENOUS AGONIST IN THE TREATMENT OF SEIZURES</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Sarentis</gtr:companyName><gtr:description>Start-up founded by Dr Denise Barbut, New York</gtr:description><gtr:id>F4EA5516-BA7F-4446-84AE-A25C26D9EC6A</gtr:id><gtr:impact>Sarentis is currently seeking investment to take our gene therapy into clinical trials</gtr:impact><gtr:yearCompanyFormed>2015</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8CF6E662-9998-4D3E-ABF2-3227EE5D5119"><gtr:id>8CF6E662-9998-4D3E-ABF2-3227EE5D5119</gtr:id><gtr:title>Long-term potentiation in hippocampal oriens interneurons: postsynaptic induction, presynaptic expression and evaluation of candidate retrograde factors.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ae2a25850360f65ec63f35761b26fa8"><gtr:id>1ae2a25850360f65ec63f35761b26fa8</gtr:id><gtr:otherNames>Nicholson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2724621E-81C3-4B4A-8CBF-30BAABCC5737"><gtr:id>2724621E-81C3-4B4A-8CBF-30BAABCC5737</gtr:id><gtr:title>Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/110682094a421646bda298b3e8358061"><gtr:id>110682094a421646bda298b3e8358061</gtr:id><gtr:otherNames>Davies G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6A5F41D-B329-4A53-A023-65A7D2B573D5"><gtr:id>E6A5F41D-B329-4A53-A023-65A7D2B573D5</gtr:id><gtr:title>Interneurons go plastic.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D82370CE-AAA7-4350-A449-D2A9EAB0C357"><gtr:id>D82370CE-AAA7-4350-A449-D2A9EAB0C357</gtr:id><gtr:title>Neurological channelopathies.</gtr:title><gtr:parentPublicationTitle>Annual review of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0147-006X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA961932-9885-4737-96D8-AEA0F31E4528"><gtr:id>FA961932-9885-4737-96D8-AEA0F31E4528</gtr:id><gtr:title>LTP and LTD in cortical GABAergic interneurons: emerging rules and roles.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D096E5FC-C719-45CE-BE12-23074D37D174"><gtr:id>D096E5FC-C719-45CE-BE12-23074D37D174</gtr:id><gtr:title>Group I mGluR agonist-evoked long-term potentiation in hippocampal oriens interneurons.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f1f054a23850a0fa11dfd04fb4f1335"><gtr:id>3f1f054a23850a0fa11dfd04fb4f1335</gtr:id><gtr:otherNames>Le Duigou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED1CB742-8806-4F42-A3CD-72E2A0A35090"><gtr:id>ED1CB742-8806-4F42-A3CD-72E2A0A35090</gtr:id><gtr:title>Independent regulation of basal neurotransmitter release efficacy by variable Ca&amp;sup2;+ influx and bouton size at small central synapses.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dee3b9490f57d9ac4d64b01c8d5be195"><gtr:id>dee3b9490f57d9ac4d64b01c8d5be195</gtr:id><gtr:otherNames>Ermolyuk YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED61511D-B3CF-4508-B5EA-2BED7524CB69"><gtr:id>ED61511D-B3CF-4508-B5EA-2BED7524CB69</gtr:id><gtr:title>Induction of Anti-Hebbian LTP in CA1 Stratum Oriens Interneurons: Interactions between Group I Metabotropic Glutamate Receptors and M1 Muscarinic Receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f1f054a23850a0fa11dfd04fb4f1335"><gtr:id>3f1f054a23850a0fa11dfd04fb4f1335</gtr:id><gtr:otherNames>Le Duigou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ADE6D1BB-9A88-4351-99EE-E615F60E6AE0"><gtr:id>ADE6D1BB-9A88-4351-99EE-E615F60E6AE0</gtr:id><gtr:title>Myasthenia gravis--treatment of acute severe exacerbations in the intensive care unit results in a favourable long-term prognosis.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f804d3e647f618a01cc6307129f5106"><gtr:id>6f804d3e647f618a01cc6307129f5106</gtr:id><gtr:otherNames>Spillane J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68186199-09CC-43B3-917E-55CE19BE0434"><gtr:id>68186199-09CC-43B3-917E-55CE19BE0434</gtr:id><gtr:title>Mapping out hippocampal inhibition.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1720c9310e979d84f014606ac327cda3"><gtr:id>1720c9310e979d84f014606ac327cda3</gtr:id><gtr:otherNames>Oren I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EF80519-C4DF-4148-ABEE-2264CA69247B"><gtr:id>4EF80519-C4DF-4148-ABEE-2264CA69247B</gtr:id><gtr:title>Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>F1000 biology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-594X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/442A8BC4-6EC2-4B67-94D6-B56C2284271B"><gtr:id>442A8BC4-6EC2-4B67-94D6-B56C2284271B</gtr:id><gtr:title>Spike-timing dependent plasticity in inhibitory circuits.</gtr:title><gtr:parentPublicationTitle>Frontiers in synaptic neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/771dec6e39674e34ffad5286ff5cef53"><gtr:id>771dec6e39674e34ffad5286ff5cef53</gtr:id><gtr:otherNames>Lamsa KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1663-3563</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0694F30-91FA-4FFF-B4D9-755CA8DF2B1F"><gtr:id>B0694F30-91FA-4FFF-B4D9-755CA8DF2B1F</gtr:id><gtr:title>Differential triggering of spontaneous glutamate release by P/Q-, N- and R-type Ca2+ channels.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dee3b9490f57d9ac4d64b01c8d5be195"><gtr:id>dee3b9490f57d9ac4d64b01c8d5be195</gtr:id><gtr:otherNames>Ermolyuk YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/117E3B68-5779-437E-B700-B547D60E337A"><gtr:id>117E3B68-5779-437E-B700-B547D60E337A</gtr:id><gtr:title>Kv1.1 channelopathy abolishes presynaptic spike width modulation by subthreshold somatic depolarization.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc1ff082016dd34c0b053ded4582c910"><gtr:id>bc1ff082016dd34c0b053ded4582c910</gtr:id><gtr:otherNames>Vivekananda U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/452E3433-7B64-4093-8F0B-34A5EF62E095"><gtr:id>452E3433-7B64-4093-8F0B-34A5EF62E095</gtr:id><gtr:title>Optogenetic approaches to treat epilepsy.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab5d922700c9e9c3deb2ccbcc87b9667"><gtr:id>ab5d922700c9e9c3deb2ccbcc87b9667</gtr:id><gtr:otherNames>Wykes RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71AA0C10-CCDF-4026-9E6F-78AF364F4E42"><gtr:id>71AA0C10-CCDF-4026-9E6F-78AF364F4E42</gtr:id><gtr:title>Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B8754A27-A24E-4B5F-BB54-38256813C829"><gtr:id>B8754A27-A24E-4B5F-BB54-38256813C829</gtr:id><gtr:title>Chemical-genetic attenuation of focal neocortical seizures.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e71c4ba694ccab7ce7b6754c5c8856a6"><gtr:id>e71c4ba694ccab7ce7b6754c5c8856a6</gtr:id><gtr:otherNames>K?tzel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E08DBBD-CCAA-45A4-9282-DFBADC7C2176"><gtr:id>3E08DBBD-CCAA-45A4-9282-DFBADC7C2176</gtr:id><gtr:title>Alternative splicing modulates inactivation of type 1 voltage-gated sodium channels by toggling an amino acid in the first S3-S4 linker.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2748097c5a93b216cbf5bf41ebdbb3ad"><gtr:id>2748097c5a93b216cbf5bf41ebdbb3ad</gtr:id><gtr:otherNames>Fletcher EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A3B2C17-818B-4058-82F7-8E66AC946E62"><gtr:id>2A3B2C17-818B-4058-82F7-8E66AC946E62</gtr:id><gtr:title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB6E58B1-8CA2-4DDF-987F-ADDC27112D37"><gtr:id>EB6E58B1-8CA2-4DDF-987F-ADDC27112D37</gtr:id><gtr:title>Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb8609980b875605d79eaad613f6e13b"><gtr:id>eb8609980b875605d79eaad613f6e13b</gtr:id><gtr:otherNames>St?dberg T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E02029D-A9D9-471A-A431-2EBD4775443D"><gtr:id>1E02029D-A9D9-471A-A431-2EBD4775443D</gtr:id><gtr:title>Presynaptic GABAA receptors enhance transmission and LTP induction at hippocampal mossy fiber synapses.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c038419a225a2c0964dbe5a40ee0af2e"><gtr:id>c038419a225a2c0964dbe5a40ee0af2e</gtr:id><gtr:otherNames>Ruiz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BCDBD7D-F3DD-400A-871C-0C07F59BA8DE"><gtr:id>8BCDBD7D-F3DD-400A-871C-0C07F59BA8DE</gtr:id><gtr:title>Monitoring Ca(2+) elevations in individual astrocytes upon local release of amyloid beta in acute brain slices.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8747854f4eaa566ca42806d90b4788f"><gtr:id>a8747854f4eaa566ca42806d90b4788f</gtr:id><gtr:otherNames>Tyurikova O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1280364A-4A88-4C01-8393-DC1CB317E2B9"><gtr:id>1280364A-4A88-4C01-8393-DC1CB317E2B9</gtr:id><gtr:title>Cortical inhibition, pH and cell excitability in epilepsy: what are optimal targets for antiepileptic interventions?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1dfdefb4f074acaad26adccba29954d"><gtr:id>b1dfdefb4f074acaad26adccba29954d</gtr:id><gtr:otherNames>Pavlov I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02965300-1009-42DB-A3F0-DAFB61CA2B5F"><gtr:id>02965300-1009-42DB-A3F0-DAFB61CA2B5F</gtr:id><gtr:title>Probing nano-organization of astroglia with multi-color super-resolution microscopy.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69dcf6188fc2ade5d38a94dde1e4fa5a"><gtr:id>69dcf6188fc2ade5d38a94dde1e4fa5a</gtr:id><gtr:otherNames>Heller JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0360-4012</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/806912C8-FDD3-4070-BCCE-F9859C130AEC"><gtr:id>806912C8-FDD3-4070-BCCE-F9859C130AEC</gtr:id><gtr:title>Nanoscale diffusion in the synaptic cleft and beyond measured with time-resolved fluorescence anisotropy imaging.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c627dd571e8c464824c2fe898f7d2aa7"><gtr:id>c627dd571e8c464824c2fe898f7d2aa7</gtr:id><gtr:otherNames>Zheng K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21527887-4824-41A9-911F-D8F4AB19D8AF"><gtr:id>21527887-4824-41A9-911F-D8F4AB19D8AF</gtr:id><gtr:title>Ionotropic receptors at hippocampal mossy fibers: roles in axonal excitability, synaptic transmission, and plasticity.</gtr:title><gtr:parentPublicationTitle>Frontiers in neural circuits</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d402a9df0eb39b6fd339fc56c1ba58d"><gtr:id>1d402a9df0eb39b6fd339fc56c1ba58d</gtr:id><gtr:otherNames>Ruiz AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1662-5110</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E437013F-51AC-4F8F-80DA-B57169D20721"><gtr:id>E437013F-51AC-4F8F-80DA-B57169D20721</gtr:id><gtr:title>Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05823300-B6F8-4332-8AF2-7C608714FCC0"><gtr:id>05823300-B6F8-4332-8AF2-7C608714FCC0</gtr:id><gtr:title>In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44B6B9AB-CC70-4606-B519-FDF93D0CBC39"><gtr:id>44B6B9AB-CC70-4606-B519-FDF93D0CBC39</gtr:id><gtr:title>Gene therapy in status epilepticus.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f13d4d30c5a901bebc5dc995df7dfd5b"><gtr:id>f13d4d30c5a901bebc5dc995df7dfd5b</gtr:id><gtr:otherNames>Walker MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54097E5B-1340-450C-8A3D-ECE7E5DEE5D3"><gtr:id>54097E5B-1340-450C-8A3D-ECE7E5DEE5D3</gtr:id><gtr:title>Endogenous zinc depresses GABAergic transmission via T-type Ca(2+) channels and broadens the time window for integration of glutamatergic inputs in dentate granule cells.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6242653e54e571ca915edf1023490a45"><gtr:id>6242653e54e571ca915edf1023490a45</gtr:id><gtr:otherNames>Grauert A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48054D22-C291-4C06-B5B1-506E99ADABEF"><gtr:id>48054D22-C291-4C06-B5B1-506E99ADABEF</gtr:id><gtr:title>Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.</gtr:title><gtr:parentPublicationTitle>Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1388-2457</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FDCA716-4BBA-4625-98EC-834B249570A9"><gtr:id>0FDCA716-4BBA-4625-98EC-834B249570A9</gtr:id><gtr:title>Autoimmune synaptopathies.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6837a62e3d7c04b652a506c6ef070db6"><gtr:id>6837a62e3d7c04b652a506c6ef070db6</gtr:id><gtr:otherNames>Crisp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A2477ABB-922A-4303-9D9D-AE03B469ADA9"><gtr:id>A2477ABB-922A-4303-9D9D-AE03B469ADA9</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cd004fe7995fd24fab161f71a958a5af"><gtr:id>cd004fe7995fd24fab161f71a958a5af</gtr:id><gtr:otherNames>Gilbert GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F88ECE35-DFE8-475C-9EA0-E1E4B5CE7342"><gtr:id>F88ECE35-DFE8-475C-9EA0-E1E4B5CE7342</gtr:id><gtr:title>The Mother of All Battles 20 years on: is LTP expressed pre- or postsynaptically?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57BABBFD-4C1B-4277-A041-0AF1C72F6BD1"><gtr:id>57BABBFD-4C1B-4277-A041-0AF1C72F6BD1</gtr:id><gtr:title>What's wrong with the amygdala in temporal lobe epilepsy?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58E4DD01-8299-4DC0-B056-B4D1260871E3"><gtr:id>58E4DD01-8299-4DC0-B056-B4D1260871E3</gtr:id><gtr:title>Action potential broadening in a presynaptic channelopathy.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a000a03cb66c1654cd524d32ba012eb7"><gtr:id>a000a03cb66c1654cd524d32ba012eb7</gtr:id><gtr:otherNames>Begum R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/397373AC-3342-4318-8ED5-B32AD2897669"><gtr:id>397373AC-3342-4318-8ED5-B32AD2897669</gtr:id><gtr:title>Short- and long-term depression at glutamatergic synapses on hippocampal interneurons by group I mGluR activation.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f1f054a23850a0fa11dfd04fb4f1335"><gtr:id>3f1f054a23850a0fa11dfd04fb4f1335</gtr:id><gtr:otherNames>Le Duigou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD25C892-E81F-4CC2-B451-7B2466429110"><gtr:id>CD25C892-E81F-4CC2-B451-7B2466429110</gtr:id><gtr:title>Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f804d3e647f618a01cc6307129f5106"><gtr:id>6f804d3e647f618a01cc6307129f5106</gtr:id><gtr:otherNames>Spillane J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CEBFF12-E7CE-4EE6-B594-84DB7794FBE1"><gtr:id>6CEBFF12-E7CE-4EE6-B594-84DB7794FBE1</gtr:id><gtr:title>Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/028b8bbb8dfff360ef2bef1adcd6440a"><gtr:id>028b8bbb8dfff360ef2bef1adcd6440a</gtr:id><gtr:otherNames>Bygrave AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/75DD962B-627C-4B0A-AB60-1F22F47403A2"><gtr:id>75DD962B-627C-4B0A-AB60-1F22F47403A2</gtr:id><gtr:title>Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95a8882d6b6ca14f034fcc78604f6a4a"><gtr:id>95a8882d6b6ca14f034fcc78604f6a4a</gtr:id><gtr:otherNames>Heeroma JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D99663BF-9E57-4E8D-AA24-834C7C0C929C"><gtr:id>D99663BF-9E57-4E8D-AA24-834C7C0C929C</gtr:id><gtr:title>Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab5d922700c9e9c3deb2ccbcc87b9667"><gtr:id>ab5d922700c9e9c3deb2ccbcc87b9667</gtr:id><gtr:otherNames>Wykes RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0DCF7EF3-DF0F-42BD-8E03-E64A9C6AD316"><gtr:id>0DCF7EF3-DF0F-42BD-8E03-E64A9C6AD316</gtr:id><gtr:title>Myasthenia and related disorders of the neuromuscular junction.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f804d3e647f618a01cc6307129f5106"><gtr:id>6f804d3e647f618a01cc6307129f5106</gtr:id><gtr:otherNames>Spillane J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91C21C3E-8E53-4DBD-BBFA-275F527DBE89"><gtr:id>91C21C3E-8E53-4DBD-BBFA-275F527DBE89</gtr:id><gtr:title>In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/085b7423079ef5c45c18095ee05f5a73"><gtr:id>085b7423079ef5c45c18095ee05f5a73</gtr:id><gtr:otherNames>Tomlinson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61DE166D-A1AA-47B0-B852-322A4663BB77"><gtr:id>61DE166D-A1AA-47B0-B852-322A4663BB77</gtr:id><gtr:title>N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/32d68ec8aec7672f0b88995be79ce83f"><gtr:id>32d68ec8aec7672f0b88995be79ce83f</gtr:id><gtr:otherNames>Irani SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E96069E0-B02F-470C-B3B3-4912DA4795A4"><gtr:id>E96069E0-B02F-470C-B3B3-4912DA4795A4</gtr:id><gtr:title>Nanoscale-targeted patch-clamp recordings of functional presynaptic ion channels.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c74f2f031a8194794fe50f22d63d5c"><gtr:id>f5c74f2f031a8194794fe50f22d63d5c</gtr:id><gtr:otherNames>Novak P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C054983-CD8F-4A02-8003-C78C6E4326F3"><gtr:id>5C054983-CD8F-4A02-8003-C78C6E4326F3</gtr:id><gtr:title>T-type calcium channels contribute to NMDA receptor-independent synaptic plasticity in hippocampal regular-spiking oriens-alveus interneurons.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ae2a25850360f65ec63f35761b26fa8"><gtr:id>1ae2a25850360f65ec63f35761b26fa8</gtr:id><gtr:otherNames>Nicholson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E8BF974-AF0E-4377-ABE3-1ABF0073DA2B"><gtr:id>2E8BF974-AF0E-4377-ABE3-1ABF0073DA2B</gtr:id><gtr:title>Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3d700fecb67b99136b863c2ea912693"><gtr:id>d3d700fecb67b99136b863c2ea912693</gtr:id><gtr:otherNames>Labrum RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8CAB4C88-84A1-48E7-BB2B-0A8C2E6E5B27"><gtr:id>8CAB4C88-84A1-48E7-BB2B-0A8C2E6E5B27</gtr:id><gtr:title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5984E1E-E52C-4C20-8BFB-8D53FD5AFAD7"><gtr:id>A5984E1E-E52C-4C20-8BFB-8D53FD5AFAD7</gtr:id><gtr:title>De novo KCNA2 mutations cause hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/27FE31BD-37ED-4FEA-BD1F-0F61E9BA6C54"><gtr:id>27FE31BD-37ED-4FEA-BD1F-0F61E9BA6C54</gtr:id><gtr:title>Interneuron networks in the hippocampus.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F39B1BBF-03E8-4795-BA29-23329E753AF2"><gtr:id>F39B1BBF-03E8-4795-BA29-23329E753AF2</gtr:id><gtr:title>NMDA receptor-dependent function and plasticity in inhibitory circuits.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a78bffed74334db2c73b56a94ca9f400"><gtr:id>a78bffed74334db2c73b56a94ca9f400</gtr:id><gtr:otherNames>Moreau AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/65EA634F-2256-40AD-8E1C-8341BCA53181"><gtr:id>65EA634F-2256-40AD-8E1C-8341BCA53181</gtr:id><gtr:title>Enhanced QT shortening and persistent tachycardia after generalized seizures.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/01763fa8b34ad46c6421049627308ae1"><gtr:id>01763fa8b34ad46c6421049627308ae1</gtr:id><gtr:otherNames>Surges R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F8D53754-F6D8-4882-A188-E313169B0660"><gtr:id>F8D53754-F6D8-4882-A188-E313169B0660</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B0F2AF8-3BB4-4A60-AE90-F6F3EE759037"><gtr:id>2B0F2AF8-3BB4-4A60-AE90-F6F3EE759037</gtr:id><gtr:title>Neurological channelopathies: new insights into disease mechanisms and ion channel function.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21B7632B-9FAF-464B-857D-6C478FC9DC65"><gtr:id>21B7632B-9FAF-464B-857D-6C478FC9DC65</gtr:id><gtr:title>Genetic neurological channelopathies: molecular genetics and clinical phenotypes.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f804d3e647f618a01cc6307129f5106"><gtr:id>6f804d3e647f618a01cc6307129f5106</gtr:id><gtr:otherNames>Spillane J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9D261AA0-97D4-40B3-893F-5B703D71FE06"><gtr:id>9D261AA0-97D4-40B3-893F-5B703D71FE06</gtr:id><gtr:title>How much inhibition in an epileptiform burst?</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b1dfdefb4f074acaad26adccba29954d"><gtr:id>b1dfdefb4f074acaad26adccba29954d</gtr:id><gtr:otherNames>Pavlov I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E7837AD-1BDA-43E3-B0D7-B4FE5616C17A"><gtr:id>1E7837AD-1BDA-43E3-B0D7-B4FE5616C17A</gtr:id><gtr:title>Gene therapy in epilepsy-is it time for clinical trials?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/db5860e115fb39bc53662cfaa7f12d6a"><gtr:id>db5860e115fb39bc53662cfaa7f12d6a</gtr:id><gtr:otherNames>Kullmann DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ACEF0F4F-5D73-40FB-BF02-DF685C611E87"><gtr:id>ACEF0F4F-5D73-40FB-BF02-DF685C611E87</gtr:id><gtr:title>The clinical and genetic heterogeneity of paroxysmal dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801316</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>